CAPTURE 2 Post-Marketing Registry

Completed

Conditions studied: Carotid Artery Disease

In brief

The purposes of the registry are: 1) To provide an ongoing post-market surveillance mechanism to document clinical outcomes. 2) To provide additional information that the RX ACCULINK™ and RX ACCUNET™ can be used safely by a wide range of physicians under commercial use conditions. 3) To evaluate the adequacy of Abbott Vascular's physician training program.

Key facts

Study ID

NCT00302237

Run by

Abbott Medical Devices

People needed

6426

Starts

2006-03-01

Expected to finish

2010-05-01

Last updated by the study team

2012-12-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Informed Consent for data collection.
• Intent to use the RX ACCULINK and RX ACCUNET to treat carotid artery disease.

You may not qualify if…

• none.

Where it is running

• Abbott Vascular — Santa Clara, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.